Clomid is the brand name of clomiphene citrate, a selective estrogen receptor modulator (SERM). It blocks estrogen’s feedback in the brain, so the pituitary releases more LH and FSH and the testes make more testosterone. In 12 healthy men, 50 mg/day for 30 days raised testosterone by 146%, LH by 177% and FSH by 170% (Miller 2019).
That is why it is the drug most used off-label for post-cycle therapy (PCT) after anabolic steroids (Bandura 2026). But no study has tested Clomid after SARMs, and the post-steroid data are observational. Below: what Clomid is, its legal status, the doses studies used, what the recovery data show, side effects, and where to buy it. The full drug profile is on clomiphene for men.
What is Clomid?
Clomiphene is a non-steroidal SERM. It is a mix of two isomers: enclomiphene (trans) and zuclomiphene (cis), with 30–50% zuclomiphene according to the label (label). FDA first approved Clomid on 1 February 1967 for ovulation problems in women who want to become pregnant (Drugs@FDA). In men it is used off-label for low testosterone with low LH (secondary hypogonadism), infertility, and after steroid cycles.
Is Clomid a SARM? No. SARMs activate the androgen receptor. Clomid acts on estrogen receptors and works by making the body produce more of its own testosterone.
The two isomers behave differently. Zuclomiphene clears very slowly and builds up: in men on long-term clomiphene, its blood level was about 20 times that of enclomiphene (Helo 2017). Enclomiphene alone is sold as a separate compound; see enclomiphene for men.
Clomid legal status
| Where | Status |
|---|---|
| United States | Prescription-only. Approved for ovulation problems in women; use in men is off-label (label). |
| Germany | Listed in the Anti-Doping Act annex; acquiring or possessing a “non-small quantity” for doping in sport is an offense (AntiDopG). |
| Sport (WADA) | Prohibited at all times, S4.2. Since 2026 labs report clomifene in urine only above 2.0 ng/mL, because eggs or poultry from treated hens can leave traces (WADA TL26). |
Older versions of this page said “little to no studies” exist on Clomid and testosterone. That is no longer true: a 2022 meta-analysis pooled 19 studies with 1,642 men and found consistent rises in testosterone, LH and FSH (Huijben 2022).
Clomid dosage: what studies used
No study has tested a Clomid dose after SARMs. These are the doses used in studies of men:
| Dose | Who | How long | What happened |
|---|---|---|---|
| 25 mg/day, alone or with hCG 1,500 IU three times a week | 79 men after up to 6 months of steroids (retrospective) | Followed 12 months | Faster hormone recovery than no treatment; all groups normal by month 6. Normal sperm at 12 months: 87.5% with hCG, 69.2% clomiphene alone, 58.6% untreated (İbis 2026) |
| 50 mg/day | 12 healthy men | 30 days | Testosterone +146%, LH +177%, FSH +170% (Miller 2019) |
| 50 mg/day | 78 obese men with low testosterone (placebo-controlled) | 12 weeks | Testosterone, LH, FSH and lean mass rose; HDL fell (Soares 2018) |
| 25 mg/day (vs anastrozole 1 mg/day) | 26 infertile men with low testosterone | 12 weeks | Testosterone 571 vs 408 ng/dL; estradiol rose on clomiphene (Helo 2015) |
| 25 mg every other day, up to 50 mg every other day | 86 young men with low testosterone | Mean 19 months | Testosterone and gonadotropins rose; no major side effects recorded (Katz 2012) |
PCT guides online, including older versions of this page, describe 25–50 mg/day for about four weeks after a cycle. That is anecdotal; no study has tested it after SARMs.
How Clomid is used after SARMs, and what the evidence says
Older versions of this page claimed that strong SARMs such as S-23 and YK-11 need Clomid and that most people recover “within just a month”. The data say something more careful:
- SARMs suppress testosterone in a dose-dependent way. LGD-4033 lowered it at 0.1–1 mg/day, and levels recovered within five weeks of stopping without treatment (Basaria 2013). S-23 has only been studied in rats, where it cut LH by more than half (Jones 2009). Compound by compound: SARMs PCT.
- Recovery after steroids takes months, not weeks. In 100 amateur athletes, testosterone was back within about 3 months for most, sperm took about a year, and 11% still had low testosterone at one year (Smit 2021).
- Clomiphene may speed it up. In the 79-man study above, treated men normalized faster, but untreated men caught up by month 6 (İbis 2026). In 641 men at a UK clinic, self-reported PCT was linked with faster recovery only in men who had stopped steroids within the previous 3 months (Grant 2023).
Blood tests before and after. The way to measure suppression is a blood test before the cycle and again after the SARM has cleared: total testosterone (fasting, in the morning), LH, FSH and SHBG (Bhasin 2018). Clomiphene raises estradiol and SHBG, so those are worth measuring while on it (Huijben 2022). See SARMs bloodwork and the PCT & Bloodwork Planner.
Timing. The planner shows when each SARM is mostly cleared (five half-lives). Clomiphene’s own zuclomiphene part has no clear half-life: it builds up and stays for weeks to months, so its effect on a test does not end when the last capsule is taken (label).
Clomid side effects
| Side effect | What the evidence says | Evidence |
|---|---|---|
| Visual symptoms (blurring, spots, flashes) | Increase with dose and duration; usually reversible but can be prolonged and possibly irreversible. The label says to stop and have the eyes checked (label). | Trial |
| Mood changes, breast tenderness | 8% of men treated for more than 3 years reported side effects: mood changes, blurred vision, breast tenderness (Krzastek 2019). | Observational |
| Estradiol rise | Estradiol rose on clomiphene and fell on anastrozole in a randomized trial (Helo 2015). | Trial |
| Lower HDL cholesterol | HDL fell vs placebo at 50 mg/day over 12 weeks (Soares 2018). | Trial |
| Lower libido, energy and mood vs enclomiphene | In 66 men who used both, these were reported more often on clomiphene (Saffati 2024). | Observational |
| Hot flushes, abdominal discomfort, nausea, headache | From the label’s data in women (10.4% hot flushes). Postmarketing reports include raised liver enzymes and hepatitis; liver disease is a contraindication (label). | Trial |
On the other side: in 77 men taking clomiphene for about a year, PSA and hematocrit did not change (Chandrapal 2016).
How long Clomid stays in your system
The two isomers clear at very different speeds. The label says zuclomiphene stayed detectable for more than a month after single doses (label). In an anti-doping study, after 30 days of 50 mg/day, zuclomiphene was still found in urine 121 to more than 261 days later (Miller 2019). That long tail is why WADA now uses a 2.0 ng/mL reporting level (WADA TL26).
Clomid vs Nolvadex
No trial has compared them for recovery after SARMs or steroids. The observational post-steroid data are mostly for clomiphene. Tamoxifen has stronger evidence for preventing drug-induced breast growth (Spagnolo 2025). Older versions of this page called Clomid “stronger” than Nolvadex; no study has shown that. Full comparison: Nolvadex PCT and SARMs PCT.
Where to buy Clomid
Clomiphene is a prescription medicine in the US. Sarmguide’s current pick for research-grade clomiphene is SwissChems Clomiphene 25 mg capsules, sold for laboratory research use. SwissChems says each batch is tested by accredited third-party labs with HPLC and has a certificate of analysis. See Buy PCT and the SwissChems review.
Bottom line
Clomid raises LH, FSH and testosterone in men with a working hormone axis, and it is the best-studied PCT drug after steroids, in observational data. It has not been tested after SARMs. Its zuclomiphene part lingers for months, and its main risks are visual symptoms, mood changes and higher estradiol. Measure before and after rather than guessing.
Frequently asked questions
Is Clomid a SARM?
No, a SERMEvidence: Human data
Clomid (clomiphene) blocks estrogen feedback in the brain so the body makes more of its own testosterone. SARMs act on the androgen receptor instead.
How much Clomid do people take for PCT?
No dose tested after SARMsEvidence: Limited
No study has tested a Clomid dose after SARMs; studies in men used 25 to 50 mg/day, including 79 men after steroids. Doses in online PCT guides are anecdotal.
How long do people take Clomid for PCT?
Not defined by studiesEvidence: Human data
No study defines a length for PCT after SARMs. In a post-steroid study of 79 men, treated men recovered faster, but untreated men also had normal hormones by month 6.
Does Clomid raise estrogen?
YesEvidence: Trial
Estradiol rose on clomiphene in a randomized trial and in long-term studies, while it fell on anastrozole. A meta-analysis of 19 studies also found higher SHBG and estradiol during treatment.
What are the side effects of Clomid in men?
Vision, mood, higher estradiolEvidence: Trial
Visual symptoms (the label says to stop and have the eyes checked), mood changes and breast tenderness were reported, estradiol rose, and HDL cholesterol fell in one trial. Long-term male users reported side effects in 8% of cases.
How long does Clomid stay in your system?
Months, for the zuclomiphene partEvidence: Human data
The zuclomiphene part builds up: the label says it stayed detectable for more than a month after single doses. An anti-doping study found it in urine 121 to more than 261 days after a 30-day course.
Can you use Clomid and Nolvadex together?
Not tested togetherEvidence: Limited
No trial has tested the combination after SARMs or steroids. Both raise LH and testosterone through the same mechanism, so their side effects can add up.
Clomid or enclomiphene?
No head-to-head trialEvidence: Human data
Enclomiphene is one of Clomid's two isomers and clears in hours, while the other (zuclomiphene) builds up. In 66 men who switched from clomiphene to enclomiphene, side effects were reported less often on enclomiphene.
Is Clomid banned in sport?
Yes, at all timesEvidence: Law
WADA lists clomifene under S4.2, prohibited at all times. Since 2026, labs report it only above 2.0 ng/mL in urine because eggs or poultry from treated hens can leave traces.
Sources
- Hypothalamic-Pituitary-Testicular Axis Effects and Urinary Detection Following Clomiphene Administration in Males
- Clomiphene Citrate in off-Label Post-Cycle Therapy: Mechanisms, Efficacy and Diagnostic Challenges in Endocrine Recovery Following Anabolic Steroid Use
- CLOMID (clomiphene citrate) tablets – prescribing information (DailyMed)
- Drugs@FDA: CLOMID, NDA 016131
- Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment
- Anlage zum Anti-Doping-Gesetz (AntiDopG), BGBl. 2023 I Nr. 67
- WADA Technical Letter TL26 – Clomifene (effective 1 January 2026)
- Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis
- Post-cycle therapy after short-term anabolic-androgenic steroid use: comparative outcomes in recreational bodybuilders
- Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study
- A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men
- Outcomes of clomiphene citrate treatment in young hypogonadal men
- The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men
- Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception (S-23, rats)
- Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study
- Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
- Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism
- Safety and efficacy of enclomiphene and clomiphene for hypogonadal men
- Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels
- Prevention of bicalutamide-induced breast events in patients with prostate cancer: a meta-analysis of randomized controlled trials